Indications and uses
To help support the structure & function of the male endocrine system
To help support the structure & function of the male endocrine system
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Adrenal gland (6X, 200K), Aldosterone (15X, 200K), Androsterone (15X, 200K), cAMP / Adenosinum cyclophosphoricum (6X, 200K), Cholesterinum (6X, 200K), DHEA (6X, 200K), Growth hormone (4C, 200K), Hypothalamus (8X, 200K), Melatonin (4C, 200K), Pancreas (6X, 200K), Pineal (6X, 200K), Pituitary (6X, 200K), Prostate (6X, 200K), Testis (6X, 200K), Testosterone (6X, 200K), Thalamus (6X, 200K), Thymus (6C, 200K), Thyroid gland (200K)
| Adrenal gland | Adrenal support |
| Aldosterone | Hormonal support |
| Androsterone | Adrenal support |
| cAMP / Adenosinum cyclophosphoricum | Intra-Cellular support |
| Cholesterinum | Drainage |
| DHEA | Adrenal support |
| Growth hormone | Hormonal support |
| Hypothalamus | Regeneration |
| Melatonin | Neurological support |
| Pancreas | Regeneration |
| Pineal | Regeneration |
| Pituitary | Regeneration |
| Prostate | Regeneration |
| Testis | Regeneration |
| Testosterone | Hormonal support |
| Thalamus | Regeneration |
| Thymus | Regeneration |
| Thyroid gland | Regeneration |
To help support the structure & function of the male endocrine system
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
20% Alcohol and 80% Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0400
NDC 63776-320-15
Homeopathic remedy
Male +
• To help support the structure & functin of the male endocrine system
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Male +
50 ml
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0400
NDC: 63776-320-15
INDICATIONS:
To help support the structure & function of the male endocrine system
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-320-15 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1c09-111a-e063-dadaa90a10e2 | Male + |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-320-15 | Male plus | 1 in 1 BOX | SPRAY | 1 | 7 | |
| 63776-320-15 | Male plus | 50 mL in 1 BOTTLE, SPRAY | SPRAY | 50 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-320 | MALE PLUS (BOS TAURUS ADRENAL GLAND, SUS SCROFA ADRENAL GLAND, ALDOSTERONE, ANDROSTERONE, ADENOSINE CYCLIC 3,5-PHOSPHATE, CHOLESTEROL, PRASTERONE, SOMATROPIN, BOS TAURUS HYPOTHALAMUS, SUS SCROFA HYPOTHALAMUS, MELATONIN, BOS TAURUS PANCREAS, SUS SCROFA PANCREAS, BOS TAURUS PINEAL GLAND, SUS SCROFA PINEAL GLAND, BOS TAURUS PITUITARY GLAND, SUS SCROFA PITUITARY GLAND, BOS TAURUS PROSTATE GLAND, SUS SCROFA PROSTATE, BOS TAURUS TESTICLE, SUS SCROFA TESTICLE, TESTOSTERONE, SUS SCROFA THALAMUS) SPRAY [VIATREXX BIO INCORPORATED] | 7 | Legacy NDC, 2 package rows | 20221201_23c93f62-14b7-0045-26ae-8844de241ed0.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Adenosine Cyclic 3',5'-phosphate | ACTIVE INGREDIENT | E0399OZS9N | 1 | |
| Aldosterone | ACTIVE INGREDIENT | 4964P6T9RB | 1 | |
| Androsterone | ACTIVE INGREDIENT | C24W7J5D5R | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE INGREDIENT | M2776SWB29 | 1 | |
| Bos Taurus Hypothalamus | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| Bos Taurus Pancreas | ACTIVE INGREDIENT | 1M529TNT1D | 1 | |
| Bos Taurus Pineal Gland | ACTIVE INGREDIENT | Z7RM5NBH36 | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE INGREDIENT | 7JM57I419K | 1 | |
| Bos Taurus Prostate Gland | ACTIVE INGREDIENT | 1P66FXU2MW | 1 | |
| Bos Taurus Testicle | ACTIVE INGREDIENT | PR4RXL6G2H | 1 | |
| Bos Taurus Thymus | ACTIVE INGREDIENT | 8XEJ88V2T8 | 1 | |
| Cholesterol | ACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| Melatonin | ACTIVE INGREDIENT | JL5DK93RCL | 1 | |
| Prasterone | ACTIVE INGREDIENT | 459AG36T1B | 1 | |
| Somatropin | ACTIVE INGREDIENT | NQX9KB6PCL | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE INGREDIENT | N6R0856Z79 | 1 | |
| Sus Scrofa Pancreas | ACTIVE INGREDIENT | 9Y3J3362RY | 1 | |
| Sus Scrofa Pineal Gland | ACTIVE INGREDIENT | 050QZ2EDK7 | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| Sus Scrofa Prostate | ACTIVE INGREDIENT | O6UD3347K2 | 1 | |
| Sus Scrofa Testicle | ACTIVE INGREDIENT | KM02613O28 | 1 | |
| Sus Scrofa Thalamus | ACTIVE INGREDIENT | 3D6Q7UV74J | 1 | |
| Sus Scrofa Thymus | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| Testosterone | ACTIVE INGREDIENT | 3XMK78S47O | 1 | |
| Thyroid, Bovine | ACTIVE INGREDIENT | MN18OTN73W | 1 | |
| Thyroid, Porcine | ACTIVE INGREDIENT | 6RV024OAUQ | 1 | |
| Adenosine Cyclic 3',5'-phosphate | ACTIVE MOIETY | E0399OZS9N | 1 | |
| Aldosterone | ACTIVE MOIETY | 4964P6T9RB | 1 | |
| Androsterone | ACTIVE MOIETY | C24W7J5D5R | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE MOIETY | M2776SWB29 | 1 | |
| Bos Taurus Hypothalamus | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| Bos Taurus Pancreas | ACTIVE MOIETY | 1M529TNT1D | 1 | |
| Bos Taurus Pineal Gland | ACTIVE MOIETY | Z7RM5NBH36 | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE MOIETY | 7JM57I419K | 1 | |
| Bos Taurus Prostate Gland | ACTIVE MOIETY | 1P66FXU2MW | 1 | |
| Bos Taurus Testicle | ACTIVE MOIETY | PR4RXL6G2H | 1 | |
| Bos Taurus Thymus | ACTIVE MOIETY | 8XEJ88V2T8 | 1 | |
| Cholesterol | ACTIVE MOIETY | 97C5T2UQ7J | 1 | |
| Melatonin | ACTIVE MOIETY | JL5DK93RCL | 1 | |
| Prasterone | ACTIVE MOIETY | 459AG36T1B | 1 | |
| Somatropin | ACTIVE MOIETY | NQX9KB6PCL | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE MOIETY | N6R0856Z79 | 1 | |
| Sus Scrofa Pancreas | ACTIVE MOIETY | 9Y3J3362RY | 1 | |
| Sus Scrofa Pineal Gland | ACTIVE MOIETY | 050QZ2EDK7 | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE MOIETY | E8S87O660T | 1 | |
| Sus Scrofa Prostate | ACTIVE MOIETY | O6UD3347K2 | 1 | |
| Sus Scrofa Testicle | ACTIVE MOIETY | KM02613O28 | 1 | |
| Sus Scrofa Thalamus | ACTIVE MOIETY | 3D6Q7UV74J | 1 | |
| Sus Scrofa Thymus | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| Testosterone | ACTIVE MOIETY | 3XMK78S47O | 1 | |
| Thyroid, Bovine | ACTIVE MOIETY | MN18OTN73W | 1 | |
| Thyroid, Porcine | ACTIVE MOIETY | 6RV024OAUQ | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-320 | 63776-320-15 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb4baa9-966b-f7ea-e053-2a95a90a80a1 | 23c93f62-14b7-0045-26ae-8844de241ed0 | 2022-11-30 | Warnings | eeb4baa9-966b-f7ea-e053-2a95a90a80a1 23c93f62-14b7-0045-26ae-8844de241ed0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.